PL3294738T3 - Mono- lub di-podstawione pochodne indolowe jako inhibitory replikacji wirusa dengi - Google Patents

Mono- lub di-podstawione pochodne indolowe jako inhibitory replikacji wirusa dengi

Info

Publication number: PL3294738T3
Authority: PL; Poland
Prior art keywords: mono; viral replication; indole derivatives; substituted indole; replication inhibitors
Prior art date: 2015-05-08

Application number

PL16723965T

Other languages

English (en)

Inventor

Bart Rudolf Romanie Kesteleyn

Jean-François BONFANTI

Tim Hugo Maria Jonckers

Pierre Jean-Marie Bernard Raboisson

Dorothée Alice Marie-Eve Bardiot

Arnaud Didier M Marchand

Original Assignee

Janssen Pharmaceuticals, Inc.

Katholieke Universiteit Leuven

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2015-05-08

Filing date

2016-05-04

Publication date

2021-12-13

2016-05-04 Application filed by Janssen Pharmaceuticals, Inc., Katholieke Universiteit Leuven filed Critical Janssen Pharmaceuticals, Inc.

2021-12-13 Publication of PL3294738T3 publication Critical patent/PL3294738T3/pl

Links

208000001490 Dengue Diseases 0.000 title 1
206010012310 Dengue fever Diseases 0.000 title 1
229940123627 Viral replication inhibitor Drugs 0.000 title 1
229940054051 antipsychotic indole derivative Drugs 0.000 title 1
208000025729 dengue disease Diseases 0.000 title 1
-1 di-substituted indole Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/08—Bridged systems
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Virology (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Molecular Biology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

PL16723965T 2015-05-08 2016-05-04 Mono- lub di-podstawione pochodne indolowe jako inhibitory replikacji wirusa dengi PL3294738T3 (pl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
EP15166900		2015-05-08
EP16163342		2016-03-31
EP16723965.6A EP3294738B1 (en)	2015-05-08	2016-05-04	Mono- or di-substituted indole derivatives as dengue viral replication inhibitors
PCT/EP2016/059975 WO2016180696A1 (en)	2015-05-08	2016-05-04	Mono- or di-substituted indole derivatives as dengue viral replication inhibitors

Publications (1)

Publication Number	Publication Date
PL3294738T3 true PL3294738T3 (pl)	2021-12-13

Family

ID=56026812

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL16723965T PL3294738T3 (pl)	2015-05-08	2016-05-04	Mono- lub di-podstawione pochodne indolowe jako inhibitory replikacji wirusa dengi

Country Status (39)

Country	Link
US (5)	US10696632B2 (pl)
EP (2)	EP3294738B1 (pl)
JP (4)	JP6752821B2 (pl)
KR (2)	KR102610493B1 (pl)
CN (3)	CN111303000B (pl)
AU (2)	AU2016259677B2 (pl)
BR (1)	BR112017023904A2 (pl)
CA (1)	CA2981845C (pl)
CL (1)	CL2017002817A1 (pl)
CO (1)	CO2017012381A2 (pl)
CR (2)	CR20170490A (pl)
CY (1)	CY1124548T1 (pl)
DK (1)	DK3294738T3 (pl)
EA (1)	EA034978B1 (pl)
EC (2)	ECSP17073878A (pl)
ES (2)	ES2877404T3 (pl)
GT (1)	GT201700234A (pl)
HR (1)	HRP20210675T1 (pl)
HU (1)	HUE054724T2 (pl)
IL (2)	IL255430B (pl)
JO (2)	JOP20160086B1 (pl)
LT (1)	LT3294738T (pl)
MD (1)	MD3294738T2 (pl)
MX (2)	MX391754B (pl)
MY (1)	MY198339A (pl)
NI (1)	NI201700137A (pl)
PE (2)	PE20180232A1 (pl)
PH (1)	PH12017502000A1 (pl)
PL (1)	PL3294738T3 (pl)
RS (1)	RS62029B1 (pl)
SG (1)	SG10201900315SA (pl)
SI (1)	SI3294738T1 (pl)
SM (1)	SMT202100367T1 (pl)
SV (1)	SV2017005557A (pl)
TW (2)	TWI744963B (pl)
UA (2)	UA121332C2 (pl)
UY (2)	UY39706A (pl)
WO (1)	WO2016180696A1 (pl)
ZA (2)	ZA201707524B (pl)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB201116559D0 (en)	2011-09-26	2011-11-09	Univ Leuven Kath	Novel viral replication inhibitors
GB201305376D0 (en)	2013-03-25	2013-05-08	Univ Leuven Kath	Novel viral replication inhibitors
EP3201176B1 (en) *	2014-10-01	2018-12-12	Janssen Pharmaceuticals, Inc.	Mono- or di-substituted indole derivatives as dengue viral replication inhibitors
PL3201177T3 (pl) *	2014-10-01	2019-05-31	Janssen Pharmaceuticals Inc	Mono- lub di-podstawione indole jako inhibitory replikacji wirusa dengi
JOP20160086B1 (ar)	2015-05-08	2021-08-17	2 Katholieke Univ Leuven Ku Leuven Research And Development	مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
JO3633B1 (ar)	2015-09-16	2020-08-27	Katholieke Univ Leuven Ku Leuven Research & Development	مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
JOP20160198B1 (ar)	2015-09-16	2022-03-14	Janssen Pharmaceuticals Inc	مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
CR20180496A (es)	2016-03-31	2018-12-06	Univ Leuven Kath	Derivados de indolina sustituidos como inhibidores de la replicación vírica de dengue
WO2017167950A1 (en)	2016-03-31	2017-10-05	Janssen Pharmaceuticals, Inc.	Substituted indole derivatives as dengue viral replication inhibitors
JOP20170069B1 (ar)	2016-04-01	2021-08-17	1 Janssen Pharmaceuticals Inc	مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
CN109069482B (zh)	2016-04-01	2022-04-05	杨森制药公司	作为登革热病毒复制抑制剂的经取代的吲哚化合物衍生物
JOP20180026A1 (ar)	2017-03-31	2019-01-30	Univ Leuven Kath	مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
JOP20180025B1 (ar)	2017-03-31	2021-08-17	Janssen Pharmaceuticals Inc	مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
MX393586B (es) *	2017-05-22	2025-03-24	Janssen Pharmaceuticals Inc	Derivados de indolina sustituidos como inhibidores de la replicacion virica de dengue
PE20200342A1 (es)	2017-05-22	2020-02-14	Janssen Pharmaceuticals Inc	Derivados de indolina sustituidos como inhibidores de la replicacion virica de dengue
CA3161338A1 (en)	2019-11-15	2021-05-20	Janssen Pharmaceuticals, Inc.	Treatment and prevention of dengue disease
WO2022094817A1 (en) *	2020-11-04	2022-05-12	Janssen Pharmaceuticals, Inc.	Pharmaceutical formulation
WO2022094816A1 (en)	2020-11-04	2022-05-12	Janssen Pharmaceuticals, Inc.	Solid formulation
CN113024440B (zh) *	2021-03-17	2023-05-16	凯莱英医药集团（天津）股份有限公司	连续化合成取代吲哚-2-羧酸的方法
TW202317512A (zh)	2021-06-29	2023-05-01	美商健生醫藥公司	取代的吲哚衍生物之合成
JP2025517683A (ja)	2022-05-12	2025-06-10	ヤンセンファーマシューティカルズ，インコーポレーテッド	デングウイルス感染症の治療及び／又は予防
CN115521307B (zh) *	2022-09-30	2023-09-22	甘肃皓天医药科技有限责任公司	一种5-卤代-7-氮杂吲哚的制备方法
WO2025253267A1 (en)	2024-06-06	2025-12-11	Janssen Pharmaceuticals, Inc.	Combination of mosnodenvir and close analogs with nitd-688 for use in the treatment and prevention of dengue disease
WO2026018176A1 (en)	2024-07-17	2026-01-22	Janssen Pharmaceuticals, Inc.	2-(4-chloro-2 methoxyphenyl)-2-((3-methoxy-5-(methylsulfonyl)phenyl)amino)-1-(5-(trifluoro¬methoxy)-1h-indol-3-yl)ethanone and pharmaceutical compositions comprising the same
CN119306651B (zh) *	2024-10-11	2025-12-05	山东大学	一种吲哚3-酰胺类衍生物及其制备方法与应用
CN121378100A (zh) *	2025-12-24	2026-01-23	浙江大学医学院附属第二医院	一种苯并[g]吲哚衍生物及其在制备抗登革热药物中的应用

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU1200899A (en)	1997-10-27	1999-05-17	Eli Lilly And Company	Morpholino-n-ethyl ester prodrugs of indole spla2 inhibitors
GB0110832D0 (en)	2001-05-03	2001-06-27	Virogen Ltd	Antiviral compounds
WO2003050295A2 (en)	2001-12-12	2003-06-19	Conforma Therapeutics Corporation	Assays and implements for determining and modulating hsp90 binding activity
GB0215293D0 (en)	2002-07-03	2002-08-14	Rega Foundation	Viral inhibitors
AU2006204917A1 (en)	2005-01-14	2006-07-20	Smithkline Beecham Corporation	Indole derivatives for treating viral infections
EA200701669A1 (ru)	2005-02-09	2008-02-28	Мидженикс Инк.	Композиции и способы лечения или предотвращения инфекций, вызванных вирусами семейства flaviviridae
FR2928645A1 (fr) *	2008-03-14	2009-09-18	Sanofi Aventis Sa	Nouveaux derives de carbazole inhibiteurs d'hsp90, compositions les contenant et utilisation
AP2010005480A0 (en)	2008-06-03	2010-12-31	Siga Technologies Inc	Small molecule inhibitors for the treatment or prevention of denque virus infection.
CA2733554A1 (en) *	2008-08-18	2010-02-25	Yale University	Mif modulators
US8143259B2 (en)	2008-08-19	2012-03-27	Janssen Pharmaceutica, Nv	Cold menthol receptor antagonists
TWI453207B (zh)	2008-09-08	2014-09-21	Signal Pharm Llc	胺基三唑并吡啶，其組合物及使用其之治療方法
WO2010091413A1 (en)	2009-02-09	2010-08-12	Enanta Pharmaceuticals, Inc.	Linked dibenzimidazole derivatives
GB0910003D0 (en)	2009-06-11	2009-07-22	Univ Leuven Kath	Novel compounds for the treatment of neurodegenerative diseases
US8993604B2 (en)	2009-06-30	2015-03-31	Siga Technologies, Inc.	Treatment and prevention of dengue virus infections
PT2523951E (pt)	2010-01-15	2015-09-14	Gilead Sciences Inc	Inibidores de vírus flaviviridae
JP2013523657A (ja)	2010-03-26	2013-06-17	グラクソグループリミテッド	キナーゼ阻害剤としてのインダゾリル‐ピリミジン
JP5716205B2 (ja)	2011-03-29	2015-05-13	学校法人日本大学	グルコシダーゼ活性阻害用組成物及びそのスクリーニング方法
GB201116559D0 (en)	2011-09-26	2011-11-09	Univ Leuven Kath	Novel viral replication inhibitors
GB201305376D0 (en)	2013-03-25	2013-05-08	Univ Leuven Kath	Novel viral replication inhibitors
KR102290189B1 (ko)	2013-10-23	2021-08-17	얀센 사이언시즈 아일랜드 언리미티드 컴퍼니	카르복스아미드 유도체 및 ｂ형 간염 치료용 의약으로서의 이의 용도
TWI688564B (zh)	2014-01-31	2020-03-21	美商必治妥美雅史谷比公司	作為凝血因子ｘｉａ抑制劑之具有雜環p2'基團之巨環化合物
CN106687575B (zh)	2014-06-04	2021-04-30	美国安进公司	用于收获哺乳动物细胞培养物的方法
CA2949981C (en)	2014-06-04	2023-03-14	Fred Hutchinson Cancer Research Center	Expansion and engraftment of stem cells using notch 1 and/or notch 2 agonists
PL3201177T3 (pl)	2014-10-01	2019-05-31	Janssen Pharmaceuticals Inc	Mono- lub di-podstawione indole jako inhibitory replikacji wirusa dengi
NO2721243T3 (pl)	2014-10-01	2018-10-20
EP3201176B1 (en)	2014-10-01	2018-12-12	Janssen Pharmaceuticals, Inc.	Mono- or di-substituted indole derivatives as dengue viral replication inhibitors
EP3957753B1 (en)	2014-10-10	2024-08-21	Rutgers, the State University of New Jersey	Polymerase chain reaction primers and probes for mycobacterium tuberculosis
PH12017501272B1 (en) *	2015-01-16	2023-01-11	Janssen Pharmaceuticals Inc	Indole derivatives as dengue viral replication inhibitors
AR103680A1 (es)	2015-02-23	2017-05-24	Lilly Co Eli	Inhibidores selectivos de bace1
JOP20160086B1 (ar)	2015-05-08	2021-08-17	2 Katholieke Univ Leuven Ku Leuven Research And Development	مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
DK3313816T3 (da)	2015-07-22	2023-08-21	Omeicos Therapeutics Gmbh	Metabolisk robuste analoger af cyp-eicosanoider til behandling af hjertesygdom
JOP20160198B1 (ar)	2015-09-16	2022-03-14	Janssen Pharmaceuticals Inc	مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
JO3633B1 (ar)	2015-09-16	2020-08-27	Katholieke Univ Leuven Ku Leuven Research & Development	مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
EP3370698B1 (en)	2015-11-03	2022-01-26	Zoetis Services LLC	Sol-gel polymer composites and uses thereof
WO2017167950A1 (en)	2016-03-31	2017-10-05	Janssen Pharmaceuticals, Inc.	Substituted indole derivatives as dengue viral replication inhibitors
EA036637B1 (ru)	2016-03-31	2020-12-02	Такеда Фармасьютикал Компани Лимитед	Гетероциклические спиросоединения, ингибирующие моноацилглицерин-липазу
CR20180496A (es)	2016-03-31	2018-12-06	Univ Leuven Kath	Derivados de indolina sustituidos como inhibidores de la replicación vírica de dengue
JOP20170069B1 (ar)	2016-04-01	2021-08-17	1 Janssen Pharmaceuticals Inc	مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
PT3436079T (pt)	2016-04-01	2021-10-06	Kite Pharma Inc	Recetores de antigénios quiméricos e de células t e métodos de uso
BR112018070163A2 (pt)	2016-04-01	2019-01-29	Signal Pharm Llc	compostos de aminopurina substituída, composições e métodos de tratamento
CA3015934A1 (en)	2016-04-01	2017-10-05	Basf Se	Bicyclic compounds
UA123276C2 (uk)	2016-04-01	2021-03-10	Кайт Фарма, Інк.	Химерний рецептор та спосіб лікування пухлини або злоякісного новоутворення
KR102694879B1 (ko)	2016-04-01	2024-08-16	암젠 인크	Flt3에 대한 키메라 수용체 및 이의 사용 방법
CN109069482B (zh)	2016-04-01	2022-04-05	杨森制药公司	作为登革热病毒复制抑制剂的经取代的吲哚化合物衍生物
GB2573909B (en)	2017-03-17	2020-05-20	Mitsubishi Electric Corp	Adaptive array antenna device
JOP20180026A1 (ar)	2017-03-31	2019-01-30	Univ Leuven Kath	مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
JOP20180025B1 (ar)	2017-03-31	2021-08-17	Janssen Pharmaceuticals Inc	مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
PE20200342A1 (es)	2017-05-22	2020-02-14	Janssen Pharmaceuticals Inc	Derivados de indolina sustituidos como inhibidores de la replicacion virica de dengue
MX393586B (es)	2017-05-22	2025-03-24	Janssen Pharmaceuticals Inc	Derivados de indolina sustituidos como inhibidores de la replicacion virica de dengue

2016
- 2016-05-03 JO JOP/2016/0086A patent/JOP20160086B1/ar active
- 2016-05-04 AU AU2016259677A patent/AU2016259677B2/en active Active
- 2016-05-04 EP EP16723965.6A patent/EP3294738B1/en active Active
- 2016-05-04 ES ES16723965T patent/ES2877404T3/es active Active
- 2016-05-04 DK DK16723965.6T patent/DK3294738T3/da active
- 2016-05-04 JP JP2017557923A patent/JP6752821B2/ja active Active
- 2016-05-04 SI SI201631214T patent/SI3294738T1/sl unknown
- 2016-05-04 KR KR1020217011966A patent/KR102610493B1/ko active Active
- 2016-05-04 US US15/571,930 patent/US10696632B2/en active Active
- 2016-05-04 SG SG10201900315SA patent/SG10201900315SA/en unknown
- 2016-05-04 CA CA2981845A patent/CA2981845C/en active Active
- 2016-05-04 KR KR1020177031660A patent/KR102610491B1/ko active Active
- 2016-05-04 CR CR20170490A patent/CR20170490A/es unknown
- 2016-05-04 EP EP21159479.1A patent/EP3896072B1/en active Active
- 2016-05-04 CN CN202010168278.5A patent/CN111303000B/zh active Active
- 2016-05-04 PE PE2017002377A patent/PE20180232A1/es unknown
- 2016-05-04 RS RS20210800A patent/RS62029B1/sr unknown
- 2016-05-04 MX MX2020011156A patent/MX391754B/es unknown
- 2016-05-04 CR CR20200152A patent/CR20200152A/es unknown
- 2016-05-04 UA UAA201711845A patent/UA121332C2/uk unknown
- 2016-05-04 LT LTEP16723965.6T patent/LT3294738T/lt unknown
- 2016-05-04 UA UAA201909970A patent/UA128183C2/uk unknown
- 2016-05-04 MX MX2017014293A patent/MX383932B/es unknown
- 2016-05-04 PL PL16723965T patent/PL3294738T3/pl unknown
- 2016-05-04 CN CN202110222667.6A patent/CN113045476B/zh active Active
- 2016-05-04 EA EA201792429A patent/EA034978B1/ru unknown
- 2016-05-04 MD MDE20180272T patent/MD3294738T2/ro unknown
- 2016-05-04 CN CN201680026606.XA patent/CN107873022B/zh active Active
- 2016-05-04 HU HUE16723965A patent/HUE054724T2/hu unknown
- 2016-05-04 WO PCT/EP2016/059975 patent/WO2016180696A1/en not_active Ceased
- 2016-05-04 MY MYPI2020005593A patent/MY198339A/en unknown
- 2016-05-04 PE PE2021001440A patent/PE20221579A1/es unknown
- 2016-05-04 BR BR112017023904-3A patent/BR112017023904A2/pt not_active Application Discontinuation
- 2016-05-04 SM SM20210367T patent/SMT202100367T1/it unknown
- 2016-05-04 ES ES21159479T patent/ES2941674T3/es active Active
- 2016-05-04 HR HRP20210675TT patent/HRP20210675T1/hr unknown
- 2016-05-05 TW TW109121289A patent/TWI744963B/zh active
- 2016-05-05 TW TW105113912A patent/TWI725969B/zh active
- 2016-05-06 UY UY0001039706A patent/UY39706A/es not_active Application Discontinuation
- 2016-05-06 UY UY0001036674A patent/UY36674A/es active IP Right Grant
2017
- 2017-11-01 SV SV2017005557A patent/SV2017005557A/es unknown
- 2017-11-02 GT GT201700234A patent/GT201700234A/es unknown
- 2017-11-02 PH PH12017502000A patent/PH12017502000A1/en unknown
- 2017-11-05 IL IL255430A patent/IL255430B/en active IP Right Grant
- 2017-11-07 CL CL2017002817A patent/CL2017002817A1/es unknown
- 2017-11-07 ZA ZA2017/07524A patent/ZA201707524B/en unknown
- 2017-11-07 NI NI201700137A patent/NI201700137A/es unknown
- 2017-11-07 EC ECIEPI201773878A patent/ECSP17073878A/es unknown
- 2017-11-30 CO CONC2017/0012381A patent/CO2017012381A2/es unknown
2020
- 2020-02-20 IL IL272814A patent/IL272814B/en active IP Right Grant
- 2020-04-13 JP JP2020071412A patent/JP6898493B2/ja active Active
- 2020-05-05 ZA ZA2020/02435A patent/ZA202002435B/en unknown
- 2020-05-13 US US15/930,738 patent/US10919854B2/en active Active
- 2020-11-19 AU AU2020273314A patent/AU2020273314B2/en active Active
- 2020-12-31 US US17/139,703 patent/US11827602B2/en active Active
2021
- 2021-05-10 JO JOJO/P/2021/0109A patent/JOP20210109B1/ar active
- 2021-06-09 JP JP2021096927A patent/JP7132399B2/ja active Active
- 2021-07-06 CY CY20211100607T patent/CY1124548T1/el unknown
2022
- 2022-03-25 EC ECSENADI202223220A patent/ECSP22023220A/es unknown
- 2022-08-24 JP JP2022133239A patent/JP7451626B2/ja active Active
2023
- 2023-10-19 US US18/490,072 patent/US12172959B2/en active Active
2024
- 2024-12-19 US US18/987,392 patent/US20250230127A1/en active Pending

Also Published As

Publication number	Publication date
EP3294738B1 (en)	2021-04-07
AU2016259677B2 (en)	2020-10-01
NZ765879A (en)	2024-09-27
CN107873022A (zh)	2018-04-03
NI201700137A (es)	2019-05-07
JOP20160086B1 (ar)	2021-08-17
US20240182414A1 (en)	2024-06-06
CY1124548T1 (el)	2022-07-22
UY36674A (es)	2016-11-30
JP7132399B2 (ja)	2022-09-06
SG10201900315SA (en)	2019-02-27
TWI725969B (zh)	2021-05-01
JP6752821B2 (ja)	2020-09-09
CN113045476A (zh)	2021-06-29
AU2020273314B2 (en)	2021-10-21
TW201704208A (zh)	2017-02-01
KR102610491B1 (ko)	2023-12-06
KR20210048578A (ko)	2021-05-03
JP2021138752A (ja)	2021-09-16
IL255430A0 (en)	2017-12-31
MX391754B (es)	2025-03-21
ECSP17073878A (es)	2018-02-28
EA034978B1 (ru)	2020-04-14
EP3896072B1 (en)	2022-11-16
AU2020273314A1 (en)	2020-12-17
RS62029B1 (sr)	2021-07-30
US10696632B2 (en)	2020-06-30
CR20200152A (es)	2020-09-08
US11827602B2 (en)	2023-11-28
HUE054724T2 (hu)	2021-09-28
HRP20210675T1 (hr)	2021-06-25
EP3896072A1 (en)	2021-10-20
EP3294738A1 (en)	2018-03-21
JOP20210109A1 (ar)	2023-01-30
IL272814A (en)	2020-04-30
UA121332C2 (uk)	2020-05-12
KR102610493B1 (ko)	2023-12-05
JP6898493B2 (ja)	2021-07-07
PH12017502000B1 (en)	2018-03-26
SMT202100367T1 (it)	2021-07-12
ZA201707524B (en)	2024-06-26
IL272814B (en)	2021-02-28
KR20180002644A (ko)	2018-01-08
CA2981845A1 (en)	2016-11-17
US12172959B2 (en)	2024-12-24
SV2017005557A (es)	2018-06-26
DK3294738T3 (da)	2021-06-28
TW202041499A (zh)	2020-11-16
MY198339A (en)	2023-08-27
CN111303000B (zh)	2023-11-28
HK1252446A1 (zh)	2019-05-24
IL255430B (en)	2020-03-31
CN111303000A (zh)	2020-06-19
MX2020011156A (es)	2022-04-21
ECSP22023220A (es)	2022-05-31
JP7451626B2 (ja)	2024-03-18
AU2016259677A1 (en)	2017-10-26
JOP20210109B1 (ar)	2024-12-22
MD3294738T2 (ro)	2021-08-31
CA2981845C (en)	2022-03-08
HK1252496A1 (zh)	2019-05-31
US20250230127A1 (en)	2025-07-17
CO2017012381A2 (es)	2018-03-28
PE20221579A1 (es)	2022-10-06
ES2877404T3 (es)	2021-11-16
MX383932B (es)	2025-03-14
JP2018515495A (ja)	2018-06-14
MX2017014293A (es)	2018-08-09
JP2022166289A (ja)	2022-11-01
CL2017002817A1 (es)	2018-05-11
ES2941674T3 (es)	2023-05-24
PH12017502000A1 (en)	2018-03-26
CN107873022B (zh)	2021-03-12
GT201700234A (es)	2018-11-26
EA201792429A1 (ru)	2018-02-28
US20180346419A1 (en)	2018-12-06
US20210171462A1 (en)	2021-06-10
US20200270209A1 (en)	2020-08-27
US10919854B2 (en)	2021-02-16
LT3294738T (lt)	2021-08-25
JP2020125316A (ja)	2020-08-20
ZA202002435B (en)	2023-03-29
TWI744963B (zh)	2021-11-01
UY39706A (es)	2022-05-31
PE20180232A1 (es)	2018-01-31
WO2016180696A1 (en)	2016-11-17
UA128183C2 (uk)	2024-05-01
NZ736934A (en)	2023-11-24
BR112017023904A2 (pt)	2018-07-17
SI3294738T1 (sl)	2021-08-31
CN113045476B (zh)	2024-07-16
CR20170490A (es)	2018-03-08

Publication	Publication Date	Title
ZA202002435B (en)	2023-03-29	Mono- or di-substituted indole derivatives as dengue viral replication inhibitors
IL258043B (en)	2021-08-31	Mono- or di-converted indoles as inhibitors of dengue virus replication
ZA201801764B (en)	2021-04-28	Mono- or di-substituted indole derivatives as dengue viral replication inhibitors
ZA201702301B (en)	2018-12-19	Mono- or di-substituted indole derivatives as dengue viral replication inhibitors
ZA201806482B (en)	2021-04-28	Substituted indoline derivatives as dengue viral replication inhibitors
ZA201702299B (en)	2018-12-19	Mono- or di-substituted indoles as dengue viral replication inhibitors
ZA201806473B (en)	2020-05-27	Substituted indole derivatives as dengue viral replication inhibitors
IL261943A (en)	2018-10-31	Transformed indulin derivatives as inhibitors of dengue virus replication
ZA201704783B (en)	2019-01-30	Indole derivatives as dengue viral replication inhibitors
IL261947A (en)	2018-10-31	History of converted indole compounds as inhibitors of dengue virus replication
LT3601225T (lt)	2021-08-10	Pakeistieji indolino dariniai kaip dengės viruso replikacijos inhibitoriai
PT3294738T (pt)	2021-06-30	Derivados mono ou di-substituídos de indol como inibidores da replicação viral da dengue